e-learning
resources
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The use of ß
2
-adrenoreceptor agonists in viral bronchiolitis: scientific rationale beyond evidence-based guidelines
Gustavo Nino, Carlos E. Rodríguez-Martínez, Jose A. Castro-Rodriguez
Source:
ERJ Open Res, 6 (4) 00135-2020; 10.1183/23120541.00135-2020
Journal Issue:
October
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Gustavo Nino, Carlos E. Rodríguez-Martínez, Jose A. Castro-Rodriguez. The use of ß
2
-adrenoreceptor agonists in viral bronchiolitis: scientific rationale beyond evidence-based guidelines. ERJ Open Res, 6 (4) 00135-2020; 10.1183/23120541.00135-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Cough clinical practice guidelines: A critical review of scientific evidence and recommendations
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
How do the new guidelines work? Practical approach to the new guidelines for asthma diagnosis in children, discussion and Q&A
Source: Virtual Congress 2021 – The ERS guidelines for the diagnosis of asthma in children aged 5-16 years
Year: 2021
Emerging challenges to the development and implementation of clinical practice guidelines – COPD as a case in point
Source: Annual Congress 2008 - Guideline development workshop summary: ATS/ERS integrating and coordinating efforts in COPD
Year: 2008
How to apply evidence based practice critique method to review of guidelines
Source: Annual Congress 2005 - Workshop: evidence-based practice: an approach to care
Year: 2005
Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018
The new ATS/ERS/IDSA/CDC guidelines for MDR-TB: rationale, methods and recommendations
Source: International Congress 2019 – Managing drug-resistant tuberculosis: from new guidelines to clinical practice
Year: 2019
Respiratory medicines for children: current evidence, unlicensed use and research priorities
Source: Eur Respir J 2010; 35: 247-265
Year: 2010
Current management of acute bronchiolitis in Switzerland after implementation of new guidelines in 2003
Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome
Year: 2007
What is the difference between an evidence-based guideline and a consensus statement?
Source: Annual Congress 2006 - PG16 - The use of evidence-based medicine and practice for the clinician (jointly organised with the ACCP)
Year: 2006
Use and misuse of clinical and evidence-based guidelines in clinical practice
Source: Annual Congress 2009 - Physiotherapy for the respiratory patient: evidence-based guidelines
Year: 2009
Adaptation rate between COPD treatment in clinical practice and guidelines recommendations
Source: Eur Respir J 2007; 30: Suppl. 51, 779s
Year: 2007
2015 guidelines to treat IPF: an update of the 2011 guidelines - specific treatment recommendations
Source: International Congress 2015 – Treatment of idiopathic pulmonary fibrosis
Year: 2015
Developing evidence-based recommendations regarding inhalation technique in patients with COPD
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020
The new WHO air quality guidelines: policy and clinical implications for children with respiratory diseases
Source: Virtual Congress 2021 – The environment and climate change effects on lung health across the lifecourse
Year: 2021
Revising our approach to conducting therapeutic clinical research in COPD
Source: Eur Respir J, 51 (2) 1702712; 10.1183/13993003.02712-2017
Year: 2018
Translating research into practice: how are guidelines implemented?
Source: Eur Respir J 2003; 21: 23S-29S
Year: 2003
Developing a patient-centred template for asthma reviews: an IMP2ART implementation strategy
Source: International Congress 2019 – Innovations in primary care assessment and management
Year: 2019
An evidence-based, point-of-care tool to guide completion of asthma action plans in practice
Source: Eur Respir J, 49 (5) 1602238; 10.1183/13993003.02238-2016
Year: 2017
How does one develop an evidence-based guideline?
Source: Annual Congress 2006 - PG16 - The use of evidence-based medicine and practice for the clinician (jointly organised with the ACCP)
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept